New US guidelines favour one treatment for hayfever

They are in line with existing Australian recommendations

New guidelines recommend corticosteroid nasal sprays to prevent and treat seasonal allergic rhinitis in people aged 12 and over, rather than oral antihistamines or a combination of both.


Developed by a joint task force of US allergy, asthma and immunology specialists, the guidelines are in line with recommendations from the Australasian Society of Clinical Immunology and Allergy (ASCIA), which has long recommended intranasal corticosteroids as a first-line treatment.

Writing in the Annals of Internal Medicine, the authors say the evidence found no benefit to